1. Introduction {#sec1-nutrients-10-01492}
===============

Dairy is an important source of protein throughout all stages of life \[[@B1-nutrients-10-01492],[@B2-nutrients-10-01492]\]. While cow (bovine) milk is the predominant source of dairy consumed globally, alternative milk sources, including goat (caprine) milk, are also available \[[@B3-nutrients-10-01492]\]. For young children, the composition of whole cow milk may not be optimal, with more protein and fewer micronutrients (e.g., iron, vitamin D) than may be required during rapid growth and development \[[@B4-nutrients-10-01492],[@B5-nutrients-10-01492]\]. This has led to the formulation of fortified milk drinks intended to supplement the diets of children above 12 months. Fortified milk drinks have been demonstrated to reduce the incidence of inadequate micronutrient intake in circumstances of unbalanced dietary intake \[[@B6-nutrients-10-01492],[@B7-nutrients-10-01492],[@B8-nutrients-10-01492]\], while potentially limiting the risks of excessive protein intake \[[@B4-nutrients-10-01492]\]. Fortified milk products have also emerged for adolescent or adult populations such as the elderly, offering a means of caloric regulation \[[@B9-nutrients-10-01492]\] or micronutrient and protein enrichment \[[@B10-nutrients-10-01492],[@B11-nutrients-10-01492]\] of the diet.

The total protein concentration of goat milk does not differ markedly from cow milk \[[@B12-nutrients-10-01492]\], but the proportion of individual casein proteins in goat milk are more variable due to polymorphisms within the α~s1~-casein gene \[[@B13-nutrients-10-01492],[@B14-nutrients-10-01492],[@B15-nutrients-10-01492]\]. Low concentrations of α~s1~-casein in goat milk are associated with larger casein micelles \[[@B13-nutrients-10-01492],[@B16-nutrients-10-01492]\] and lower coagulation properties of rennet curd \[[@B17-nutrients-10-01492],[@B18-nutrients-10-01492],[@B19-nutrients-10-01492]\]. Since different microstructures of casein gels influence pepsin diffusion and digestion \[[@B20-nutrients-10-01492]\], it might be expected that digestion rates of fortified milk drinks made from goat milk would differ from those made with cow milk. Additionally, goat milk contains greater concentrations of key essential amino acids (AA), including cysteine, tyrosine and lysine, and the branched-chain AAs (BCAAs), isoleucine and valine \[[@B3-nutrients-10-01492]\], although values reported in the literature vary \[[@B21-nutrients-10-01492]\].

Based on the available evidence, it can be hypothesised that the protein digestion of fortified milk drinks derived from either cow or goat milk will differ. It is hypothesised that due to the differing casein and coagulation properties, goat milk would be digested more rapidly \[[@B22-nutrients-10-01492],[@B23-nutrients-10-01492]\] as a consequence of increased gastric transit \[[@B24-nutrients-10-01492]\]. However, this has not previously been analysed clinically. Partially-hydrolysed bovine whey fortified milks have also been proposed as alternatives to intact milk proteins in situations of heightened paediatric digestive discomfort \[[@B25-nutrients-10-01492]\]. For adults, hydrolysates are a common ingredient in supplemented protein formulations, with potential advantages for protein metabolism \[[@B26-nutrients-10-01492]\]. It can be further hypothesised that partially-hydrolysed bovine whey-fortified milk would elicit faster amino acid appearance \[[@B26-nutrients-10-01492]\] and different digestive responses on the basis of different gastric emptying, as previously reported \[[@B27-nutrients-10-01492]\]. To investigate this, the digestive responses, subsequent to the ingestion of either whole cow-protein (WC) fortified milk, whole goat-protein (WG) fortified milk, or a partially-hydrolysed whey cow-protein (HC) fortified milk product, were analysed in young adults. This included measurement of the rate of gastric emptying, rate of gastrointestinal transit, and subjective digestive comfort. Further, plasma hormonal (insulin and glucagon-like protein-1 (GLP-1)) and AA responses were measured. This study was conducted in young healthy adults, enabling the collection of both subjective reporting of digestive comfort and multiple biological samples.

2. Materials and Methods {#sec2-nutrients-10-01492}
========================

2.1. Subjects {#sec2dot1-nutrients-10-01492}
-------------

A total of 31 healthy men (*n* = 15) and women (*n* = 16) aged 18--28 years were recruited to participate using digital and print advertisements. One subject withdrew prior to completion of the protocol ([Figure 1](#nutrients-10-01492-f001){ref-type="fig"}). The study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all procedures involving human subjects were approved by the Southern Health and Disability Ethics Committee (New Zealand, 15/STH/167). Written informed consent was obtained from all subjects. Prospective clinical trial registration was registered at [www.anzctr.org.au](www.anzctr.org.au) (ACTRN12615001359527).

All participants self-reported lactose tolerance, without current or past history of gastrointestinal diseases including gastric reflux, irritable bowel syndrome, inflammatory bowel disease and Crohn's disease, anosmia, or any regular medication use impacting digestive function (i.e., stomach acid regulators). Further, all subjects reported no metabolic or cardiovascular disease. Participants were ineligible if they had a self-reported allergy to dairy or paracetamol, or had an alcohol intake exceeding 28 units/week. No participant was engaged in athletic or extreme physical activities. All participants reported a regular consumption of dairy products.

2.2. Experimental Design {#sec2dot2-nutrients-10-01492}
------------------------

A cross-over design was used with a treatment arm sequence randomly generated by [www.randomizer.org](www.randomizer.org) \[[@B28-nutrients-10-01492]\]. The sequence allocation was concealed in sealed envelopes assigned to participants before the intervention. Investigators and participants were blinded to treatment identity for the duration of data analysis. However, no sensory masking of products was employed.

2.3. Study Procedures {#sec2dot3-nutrients-10-01492}
---------------------

Subjects attended the Maurice Paykel Clinical Research Unit at the University of Auckland between January and April 2016 on three occasions, separated by at least one week but no more than two weeks. The day before each visit, subjects were asked to abstain from vigorous physical exercise, to avoid foods high in fat, and to avoid fibre, lactose, fructose, and artificial sweeteners; subjects were provided guidelines for food choices based on the standard preparation for hydrogen breath testing. Subjects were asked to avoid the use of laxatives and antacids. Subjects were provided with a standardised low fat, low fibre evening meal and remained fasted from 10 pm the night prior to the intervention.

Upon arrival, subjects were weighed (Tanita^®^ 1582 Medical Scale, Wedderburn, Auckland, New Zealand) and a venous cannula inserted for fasting blood sample collection. Further, fasting breath samples were collected and visual analogue scale (VAS) questionnaires for gastrointestinal symptomology completed. Subjects then consumed 500--900 mL of the randomised fortified milk drink including 1.5 g of paracetamol dissolved in a 300 mL portion of the milk. Fortified milk doses were calculated to provide 0.23 g/kg body weight of protein in a single serve \[[@B29-nutrients-10-01492]\], and were individualised for each subject. Recovery of plasma paracetamol was used as a proxy for gastric emptying \[[@B30-nutrients-10-01492]\].

Thereafter, blood samples were collected every 15 min until 90 min, and then hourly between 2 and 5 h. Breath samples were provided every 30 min until 5 h.

2.4. Study Treatments {#sec2dot4-nutrients-10-01492}
---------------------

Whole goat-protein (WG) fortified milk and whole cow-protein (WC) fortified milk were commercially available products manufactured by Dairy Goat Co-operative (N.Z.) Limited. The partially-hydrolysed cow whey protein (HC) fortified milk was a commercial formula manufactured by Nestlé New Zealand Limited (NAN OPTIPRO^®^ HA, Germany) and purchased in New Zealand. The formulations were provided to subjects over the course of the three visits. The nutrient and total amino acid composition of each fortified milk drink are listed in [Table 1](#nutrients-10-01492-t001){ref-type="table"} and [Table 2](#nutrients-10-01492-t002){ref-type="table"} respectively. The powdered formulas had different nutrient contents, but were made up to provide a similar protein content in the drink. The milk solid composition of the whole protein fortified milks (WG and WC) were whole and skim milk powders, while the HC fortified milk contained only whey, with no milk fat content. The vegetable oil content of the HC fortified milk was sourced from palm, canola, and sunflower oils, while the WG fortified milk contained soyabean and sunflower oils (20% wt:wt of total fat). The WC fortified milk did not contain vegetable oils. Fructose, inulin, and oligofructose were included in the WG and WC fortified milks. Additionally, WC had added inositol.

2.5. Biochemical Analysis {#sec2dot5-nutrients-10-01492}
-------------------------

Venous bloods were collected in ethylenediaminetetraacetic acid (EDTA) containing vacutainers (Becton Dickinson & Company, Mount Wellington, New Zealand). Plasma was prepared by centrifugation at 2000× *g* for 15 min at 4 °C and frozen at −80 °C, prior to analyses.

Plasma free amino acids were measured using ultra performance liquid chromatography (UPLC), as previously described \[[@B31-nutrients-10-01492]\]. In brief, 20 μL of plasma with internal standard L-Nor-Valine were acid extracted, then AccQ-tag reagent was added to the supernatant. UPLC was performed in singlicate using a Thermo Scientific Dionex Ultimate 3000 system (ThermoFisher Scientific, Dornierstrasse, Germany) with a Kinetex column preceded by a Krudkatcher inline filter (Phenomenex, Auckland, New Zealand). Three quality control plasma samples were included in each batch. The mean (range) overall coefficient of variation for the amino acids was 6.7% (2.7--13.9%). Data were captured by computer with Chromeleon 7.1 software (ThermoFisher Scientific, Dornierstrasse, Germany) and used to calculate amino acid concentrations from standard curves generated for each amino acid. Fortified milk total amino acids were measured by HPLC (Waters Corp., Milford, MA, USA) following 24 h hydrolysis in 6 M HCl containing 0.1% phenol, as previously described \[[@B32-nutrients-10-01492]\]. Cysteine and methionine were measured after prior preoxidation step with performic acid to form cysteic acid and methionine sulfone, while tryptophan underwent base hydrolysis prior to quantification. No correction was made for loss of AA during this hydrolysis.

Plasma glucose, and paracetamol were measured using a Cobas c311 clinical chemistry analyser (Roche Diagnostics, Basal, Switzerland) by enzymatic colorimetric assays (Roche, Mannheim, Germany). Plasma insulin was measured using the Cobas e411 immunoassay analyser (Roche Diagnostics, Basal, Switzerland) by electrochemiluminescence (Roche).

Appetite hormones (ghrelin, leptin, GLP-1) were measured in plasma using a flow cytometric multiplex array (Milliplex MAP Kit Human Metabolic Hormone Magnetic Bead Panel Assay, Millipore, MO, USA). Cholecystokinin (CCK) was measured by enzyme immunoassay (CCK (26--33) EIA, Phoenix Pharmaceuticals Inc., Belmont, CA, USA).

2.6. Breath Hydrogen Analysis {#sec2dot6-nutrients-10-01492}
-----------------------------

Breath samples were collected using the AlveoSampler™ Breath Test Kit and analysed with the BreathTracker H2+ (Quintron, Milwaukee, WI, USA). Data were recorded as CO~2~ corrected H~2~ concentrations (ppm) as a measurement of carbohydrate (lactose and inulin) malabsorption.

2.7. Digestive Symptoms and Appetite Visual Analogue Scales {#sec2dot7-nutrients-10-01492}
-----------------------------------------------------------

Fasting and postprandial scores of digestive symptoms and subjective appetite were assessed using a 100 mm VAS. Severity of digestive symptoms were recorded with 0 mm corresponding to 'no symptom' and 100 mm to 'the most severe symptom imaginable'. Symptoms assessed included abdominal pain/discomfort, abdominal cramps, bloating, abdominal rumbling or gurgling, flatulence, and faecal urgency. Appetite scores assessed included hunger, satisfaction, fullness, appetite, and desire to consume sweet, salty, savoury, or fatty foods, as described previously \[[@B33-nutrients-10-01492]\].

2.8. Statistical Analysis {#sec2dot8-nutrients-10-01492}
-------------------------

Sample size calculations of 30 subjects were based on previously-reported peak BCAA concentration differences at 60 min of 608 μmol/L \[[@B31-nutrients-10-01492]\], with an estimated relevant difference of 20%, a standard deviation of 198 μmol/L, power of 0.9, an α of 0.05. Plasma AAs were pooled for analysis into total AAs (TAAs), essential AAs (EAA), BCAAs, and non-essential AAs (NEAA).

Statistical analyses were undertaken using SPSS version 23 (SPSS, IBM Corporation, Armonk, NY, USA). Data are presented as means ± SEMs. Homeostatic model assessment of insulin resistance (HOMA-IR) was calculated as described previously \[[@B34-nutrients-10-01492]\]. Incremental area under the curve (AUC) was calculated after subtraction of fasting values, and was used to inform the analyte availability in circulation over the course of the postprandial period. Baseline characteristics were compared using one-factor analysis of variance (ANOVA; sex compared between subject), AUC with one-factor repeated measures ANOVA (treatment compared within subject), and three-factor repeated measures ANOVA (treatment and time compared within subject, sex compared between subject) was used for all other measures. Sidak adjusted post hoc tests were used for all multiple comparisons. The Huynh-Feldt correction was used where Mauchly's sphericity test failed. Alpha was set at *p* \< 0.05. Heat maps were created using R software version 2.15.2 with gplots (heatmap.2), RColorBrewer and colorRamps packages (R Development Core Team, Vienna, Austria).

3. Results {#sec3-nutrients-10-01492}
==========

3.1. Demographics {#sec3dot1-nutrients-10-01492}
-----------------

Male and female subjects were equally represented in the study (*n* = 30), with no difference in mean age between sexes (*p* = 0.594). Males were taller with greater body mass index (BMI), than females (*p* \< 0.001, and *p* = 0.017 respectively; [Table 3](#nutrients-10-01492-t003){ref-type="table"}). Males subjects had higher fasting glucose than female subjects (*p* = 0.001). HOMA-IR and fasting insulin were not different between sexes (*p* = 0.955 and *p* = 0.528, respectively).

3.2. Postprandial Amino Acid Response {#sec3dot2-nutrients-10-01492}
-------------------------------------

TAA, BCAA, EAA, and NEAA plasma concentrations peaked 60 min after ingestion for all fortified milks (*p* \< 0.001), and subsequently declined throughout the intervention (300 min). Most apparent was the accelerated reductions in TAA, BCAA, and EAA for the HC milk, relative to WC and WG ([Figure 2](#nutrients-10-01492-f002){ref-type="fig"}A--C). Individual amino acid responses are shown in [Figure 2](#nutrients-10-01492-f002){ref-type="fig"}E.

Alanine, lysine, and proline demonstrated the greatest increase relative to baseline concentrations; of these, lysine and proline postprandial concentrations differed between the HC and both the WC and WG drinks (interaction time × treatment; *p* \< 0.001 each, respectively). The difference for proline reflected the lower proline content of the whey-only HC fortified milk relative to the whole fortified milks ([Table 2](#nutrients-10-01492-t002){ref-type="table"}) Yet, the AUC of lysine was still greater following WG compared to HC, despite compositional differences (*p* = 0.014).

The greatest differences in amino acid response between milks were comparisons of HC with both WG and WC. Marked suppression in the BCAA (leucine, isoleucine and valine) from 120 min after HC ingestion was evident. Notable were the markedly lower plasma valine concentrations that are reflective of the low valine content of HC fortified milk.

HC milk resulted in significantly lower AUC for all measured proteogenic amino acids than either WG or WC except for alanine, isoleucine, glycine, and aspartic acid ([Table 4](#nutrients-10-01492-t004){ref-type="table"}; treatment effect, *p* \> 0.05 each, respectively). This was despite the HC milk's greater lysine, leucine, and threonine content relative to whole protein fortified milks ([Table 2](#nutrients-10-01492-t002){ref-type="table"}). Furthermore, unlike the whole protein fortified milks (WG and WC), the amino acid AUCs following HC milk were negative for many amino acids: leucine, isoleucine, valine, histidine, methionine, arginine, serine, tyrosine, and glutamic acid.

WG and WC AUC differed only for valine and tyrosine; with valine the AUC for WG was greater than both WC and HC ([Table 4](#nutrients-10-01492-t004){ref-type="table"}; *p* \< 0.001). Yet, the plasma concentrations of valine were not significantly different between WG and WC following ingestion at any specific timepoint. In contrast, the higher tyrosine in WC resulted in a higher AUC than WG milk (*p* \< 0.001). This higher tyrosine following WC was apparent as greater tyrosine concentrations than WG over the postprandial period ([Figure 2](#nutrients-10-01492-f002){ref-type="fig"}E; *p* \< 0.05 at each hour, respectively). Both leucine and isoleucine were more abundant in WC milk than WG, which coincided with greater postprandial concentrations of each (*p* \< 0.01 WC vs. WG at 1 h for leucine, *p* \< 0.01 WC vs. WG at 3 and 4 h for isoleucine, each, respectively). However, these differences were less pronounced than when compared with leucine and isoleucine-rich HC milk. Threonine, although more abundant in WG, was reduced more in plasma following WG than WC milk (*p* \< 0.01 WG vs. WC at 3 h); yet, AUC was not different (*p* \> 0.05).

3.3. Postprandial Glycaemic Response {#sec3dot3-nutrients-10-01492}
------------------------------------

All fortified milks resulted in a transient increase in blood glucose that tended to return to fasting levels by 75 min post-ingestion. HC exhibited a rebound rise in plasma glucose at 90 and 120 min (*p* \< 0.05 compared to WG at both time points; *p* = 0.008 compared to WC at 120 min; [Figure 3](#nutrients-10-01492-f003){ref-type="fig"}A).

3.4. Plasma Hormone Response {#sec3dot4-nutrients-10-01492}
----------------------------

HC resulted in an increased insulin response, relative to both WC and WG, with greater insulin concentrations from 30 to 180 min post-ingestion (*p* \< 0.05 between each formula, respectively; [Figure 3](#nutrients-10-01492-f003){ref-type="fig"}B). Insulin AUC was greatest after HC, followed by WC and WG (8089 ± 1396, 5202 ± 788, and 3796 ± 518 µU·min/mL, respectively; interaction time × treatment; *p* \< 0.001; no figure shown). Baseline plasma leptin concentrations were greater in female subjects (5472 ± 205 vs. 1965 ± 132 pg/mL in males, *p* \< 0.001), although postprandial responses did not differ between sexes. Plasma hormone responses to milks tended to be similar with both WC and WG. Differences were present following ingestion of HC fortified milk, with higher leptin at 240 min (compared to WG; *p* = 0.038; [Figure 3](#nutrients-10-01492-f003){ref-type="fig"}C) and higher GLP-1 at 30 and 60 min (compared to both WC and WG; *p* \< 0.05 each, respectively; [Figure 3](#nutrients-10-01492-f003){ref-type="fig"}D). Neither ghrelin nor CCK differed between fortified milks (data not shown).

3.5. Plasma Paracetamol Recovery {#sec3dot5-nutrients-10-01492}
--------------------------------

Plasma paracetamol recovery differed significantly between fortified milks (time × treatment interaction *p* \< 0.001). WC and WG milks exhibited a similar response curve, whilst paracetamol recovery was delayed with HC ingestion for the first 90 min post-ingestion ([Figure 4](#nutrients-10-01492-f004){ref-type="fig"}A). Total paracetamol recovery (AUC), did not differ between fortified milks (HC: 2742 ± 163, WC: 2816 ± 234, and WG: 2861 ± 187 mmol·min/mL, respectively, *p* = 0.724).

3.6. Breath Hydrogen {#sec3dot6-nutrients-10-01492}
--------------------

Changes in breath hydrogen concentrations differed significantly between fortified milks (time × treatment interaction *p* = 0.016, [Figure 4](#nutrients-10-01492-f004){ref-type="fig"}B). WC and WG fortified milks showed a similar response curve, while increases in HC breath hydrogen were delayed (*p* = 0.046 between WG and HC at 240 min, *p* = 0.970 and *p* = 0.222 between WG and WC, WC and HC, respectively).

3.7. Digestive Comfort and Appetite Scores {#sec3dot7-nutrients-10-01492}
------------------------------------------

Digestive comfort scores did not differ between fortified milks. *Bloating* and *flatulence* scores increased after ingestion, regardless of milk type (time effect, *p* \< 0.001 and *p* = 0.009, respectively; [Figure 5](#nutrients-10-01492-f005){ref-type="fig"}A,B). No other symptom scores differed (data not shown).

Appetite scores differed between fortified milks (interaction time × treatment; *p* = 0.025; [Figure 5](#nutrients-10-01492-f005){ref-type="fig"}C). The HC suppressed appetite relative to baseline continuously until 90 min (*p* \< 0.05), WC continuously until 75 min (*p* \< 0.05) and WG until 45 min, and again at 90 min (*p* \< 0.05, each respectively). *Appetite* scores were lower after HC between 120 and 180 min (*p* = 0.024 between HC and WC at 75 min and *p* = 0.012 and *p* = 0.035 from 120 to 180 min, respectively; *p* = 0.030 between HC and WG at 120). Scores for *hunger*, *fullness*, and desire to eat *sweet*, *salty*, *savoury*, or *fatty* food were not different between fortified milks (data not shown).

4. Discussion {#sec4-nutrients-10-01492}
=============

The digestive, metabolic, and subjective analysis of digestive responses following ingestion of fortified milks, formulated with either whole milk proteins (bovine or caprine) or partially-hydrolysed bovine whey protein, were analysed in healthy young adults. In contrast to the hypothesis, it was demonstrated that irrespective of the originating *bovidae* species, whole protein fortified milks were digested and metabolised similarly. Thus, amino acid appearance and the hormonal responses influenced by protein digestion, including GLP-1, CCK, and insulin, did not differ markedly between these whole protein fortified milks. Across most measures of digestion and hormone concentrations, partially-hydrolysed bovine fortified milk led to markedly different digestive responses. The response to partially-hydrolysed bovine fortified milk included an exaggerated insulin response with markedly suppressed BCAA appearance in plasma. No difference in subjective comfort was reported between the fortified milk drinks.

Despite the differences in amino acid composition among the WG, WC, and HC fortified milks in the current study, the most substantial difference in amino acid response was observed between the partially-hydrolysed relative to whole protein fortified milks. After 1 h, the circulating AA concentrations after HC fortified milk were suppressed below fasting levels at all further timepoints. These lower concentrations of circulating AAs are either due to a delayed rate of digestion or increased clearance from the plasma. Paracetamol appearance, a proxy measure of gastric emptying \[[@B30-nutrients-10-01492]\] and with known limitations in describing transit \[[@B27-nutrients-10-01492]\], demonstrated a possible slowed rate of gastric emptying for HC relative to WC and WG. While the drinks were matched for protein content, they were not isoenergetic. It is likely that the higher caloric density of the partially-hydrolysed drink contributed to the delay in gastric emptying \[[@B35-nutrients-10-01492]\]. Further, the structural differences of the whole proteins compared to the partially-hydrolysed proteins may have also contributed to altered gastric emptying between fortified milk drinks \[[@B23-nutrients-10-01492]\]. Yet, it would be expected that the clotting properties of casein compared to whey protein would rather delay gastric emptying \[[@B23-nutrients-10-01492]\] in the whole protein fortified milk. In addition, the structural differences of protein hydrolysation have been shown not to impact gastric emptying in isoenergetic comparisons \[[@B35-nutrients-10-01492]\]. However, this difference is unlikely to account for the substantial differences in circulating AA. Interestingly, the current findings contrast with findings of increased gastric emptying following hydrolysed formulations in infants with or without gastroesophageal reflux disorder \[[@B36-nutrients-10-01492]\], others have reported slower gastric emptying with hydrolysed formulas, and there is no clear consensus \[[@B27-nutrients-10-01492]\].

In the present study, an exaggerated incretin response (e.g., GLP-1 and insulin) was demonstrated, particularly 1 h after the HC milk ingestion, relative to the whole protein milks. Insulin is a potent regulator of amino acid transporter activity \[[@B37-nutrients-10-01492]\]; therefore, these results are suggestive of greater AA disposal with HC, relative to WC and WG. It has been previously demonstrated that gavage administration of hydrolysed whey, relative to whole whey protein, elicits greater appearance of di- and oligo-peptides, which may further account for a proportion of the measurable differences in plasma AA \[[@B38-nutrients-10-01492]\]. Whether these differences in digestion and circulating AA concentrations impact on major pathways of protein metabolism, including synthesis and oxidation, is yet to be explored.

The digestive responses of gastric emptying rates (paracetamol recovery) and gastrointestinal transit (breath hydrogen) following ingestion of the whole protein fortified milks (goat and cow) were very similar. Whole goat and cow fortified milk also elicited similar satiety scores and appetite hormone levels; this aligns with reports of similarities between goat and cow dairy by others \[[@B39-nutrients-10-01492]\]. Although the increasing breath hydrogen after whole protein formulas may be expected to correlate with increasing digestive discomfort (i.e., bloating or flatulence), this was not the case. For this study, all participants self-reported dairy tolerance, and this low level of malabsorption, originating from the lactose and/or the added inulin or inositol, may have been insufficient to evoke any symptoms \[[@B40-nutrients-10-01492]\]. These similarities in gastric transit in the whole protein fortified milks occurred despite the known differences in proteins. This includes differing casein profiles which would be expected to lead to softer gastric curd formation in the goat drink \[[@B41-nutrients-10-01492]\]. Whilst curd formation may slow gastric emptying \[[@B23-nutrients-10-01492]\], other studies have failed to demonstrate this \[[@B42-nutrients-10-01492],[@B43-nutrients-10-01492]\].

This study was conducted in adults, and while adult and infant digestion differ regarding gastric emptying, digestive enzyme production, and gastric pH \[[@B44-nutrients-10-01492]\], aspects such as enzymatic secretions and hepatic metabolism are reported to reach a comparable adult capacity by 3 to 6 months of age \[[@B44-nutrients-10-01492],[@B45-nutrients-10-01492]\]. Hence, these findings should be applicable to children above the age of 12 months, for whom fortified milks are designed. It is unknown what the possible long-term impact of such short-term metabolic differences between partially-hydrolysed and whole protein formulas may be for a growing child. Delayed gastric emptying and increased satiety from partially-hydrolysed proteins might impact on appetite cues at subsequent meals. Reduced formula consumption has previously been reported in infants fed hydrolysed whey formula \[[@B46-nutrients-10-01492]\]. Alterations in nitrogen balance \[[@B47-nutrients-10-01492]\] and higher blood urea nitrogen \[[@B48-nutrients-10-01492],[@B49-nutrients-10-01492]\] have been observed in infants fed various hydrolysate formulations. In the current study, the partially-hydrolysed formula differed most with a suppressed availability of branched chain amino acids, a class of amino acids with important roles in growth \[[@B50-nutrients-10-01492]\]. This is despite the comparable BCAA in the whey-exclusive hydrolysed fortified milk. However, the impacts of these postprandial alterations in amino acid availability require further investigation.

Goat milk-based products are increasingly seen as a possible alternative to cow milk-based products. The composition of goat milk may be more similar to breastmilk for components such as amino acids \[[@B51-nutrients-10-01492]\] and nucleotides \[[@B52-nutrients-10-01492]\]. Importantly, goat milk formula performs similarly to cow milk formula, supporting infant growth and development in animal and human studies. Animal studies have shown goat milk to enhance the utilisation and retention of protein \[[@B53-nutrients-10-01492],[@B54-nutrients-10-01492]\], mineral absorption and tissue storage (including calcium \[[@B55-nutrients-10-01492],[@B56-nutrients-10-01492]\] and iron \[[@B56-nutrients-10-01492],[@B57-nutrients-10-01492],[@B58-nutrients-10-01492]\]), and intestinal fat absorption \[[@B59-nutrients-10-01492]\] as compared to cow milk. Randomised clinical trials in infants show the growth curves of children exclusively fed goat milk formula are similar to both breastmilk fed infants \[[@B60-nutrients-10-01492]\] and those fed cow milk formula \[[@B60-nutrients-10-01492],[@B61-nutrients-10-01492],[@B62-nutrients-10-01492]\]. This has been extended to demonstrate similarity in the composition of the gut microbiota \[[@B63-nutrients-10-01492]\]. The current study builds on recent comparisons of digestive responses to goat and cow dairy meals in humans \[[@B39-nutrients-10-01492]\], and provides the first evidence in humans of a comparable digestive and metabolic response to fortified milk drinks manufactured from whole goat and cow milk.

The current study did not find differences in digestive comfort between milks. However, since the subjects were not known to have dairy intolerance, this may have limited the detection of digestive tolerance differences, as significant intolerance would not be expected. This study was limited by the use of adult subjects and the inconsistent formulation in terms of energy, macronutrients, and ingredients. The HC milk had a greater caloric load, known to delay gastric emptying \[[@B35-nutrients-10-01492]\], while the high BCAA content of the whey may have elevated insulin secretion \[[@B64-nutrients-10-01492],[@B65-nutrients-10-01492]\] relative to WG and WC milks. Further differences in carbohydrate and fat content, and composition and micronutrient composition. may have equally impacted incretin responses and gastric emptying. These differences may have influenced the current findings, and as such, deserve consideration in the context of fortified milk formulations.

5. Conclusions {#sec5-nutrients-10-01492}
==============

The current study has demonstrated that fortified goat milk, compared to fortified cow milk, is digested and metabolised similarly, despite inherent compositional differences. In contrast, partially-hydrolysed fortified milk elicited marked differences in postprandial hormonal stimulation, resulting in a suppression of amino acids in circulation for the period after the first hour of ingestion. Given the importance of circulating amino acids and incretins in the regulation of appetite \[[@B24-nutrients-10-01492]\] and anabolism \[[@B66-nutrients-10-01492]\], these differences may impact feeding behaviour or have important metabolic consequences. Given these differences in the digestive and metabolic responses to partially-hydrolysed whey fortified milk, further studies are warranted to address both the impact that this may exert on appetite and protein metabolism.
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![Plasma amino acid responses following formula ingestion. (**A**) Total amino acids (TAA). (**B**) BCAA. (**C**) Essential amino acids (EAA). (**D**) Non-essential amino acids (NEAA), (**E**) Individual amino acid concentrations as fold changes. Values represent means ± SEM in μmol/L (**A**--**D**) for whole cow (WC; ●), hydrolysed cow (HC; ○), and whole goat (WG; ■) fortified milks and mean fold changes (**E**) relative to concentrations at HC fortified milk at baseline ('0'). The x-axis shows time from baseline ('0') to 5 h ('5'), for each formula (HC, WG, WC). White represents a 0 log fold change from hydrolysed cow fortified milk at baseline. Red represents a 1 log fold increase; purple represents a 2 log fold increase; green represents a 1 log decrease. There were time × treatment interactions for all amino acid groupings (TAA, BCAA, EAA, NEAA; *p* \< 0.001 each, respectively; Sidak corrected post hoc tests). Φ denotes statistical significance *p* \< 0.05 between WG and HC fortified milks; χ *p* \< 0.05 between WC and HC fortified milks (Sidak corrected post hoc tests).](nutrients-10-01492-g002){#nutrients-10-01492-f002}

![Postprandial plasma responses for glucose (**A**), insulin (**B**), leptin (**C**), and active GLP-1 (**D**). Values represent means ± SEM in mmol/L for glucose, μU/mL for insulin, pg/mL for leptin, and glucagon-like peptide-1 (GLP-1). There was a time × treatment interaction for glucose, insulin, leptin, and GLP-1 (*p* \< 0.001, *p* \< 0.001, *p* \< 0.05, and *p* \< 0.001 respectively). Φ denotes statistical significance *p* \< 0.05 between whole goat (WG; ■) and hydrolysed cow (HC; ○) fortified milks; χ *p* \< 0.05 between whole cow (WC; ●) and HC fortified milks (Sidak corrected post hoc tests).](nutrients-10-01492-g003){#nutrients-10-01492-f003}

![Postprandial plasma paracetamol (**A**) and breath hydrogen (**B**) responses. Values represent means ± SEM in μg/mL (**A**) and ppm (**B**). There was a time × treatment interaction for postprandial plasma paracetamol concentrations (*p* \< 0.001) and breath hydrogen (*p* \< 0.05). Φ denotes statistical significance *p* \< 0.05 between whole goat (WG; ■) and hydrolysed cow (HC; ○) fortified milks; χ *p* \< 0.05 between whole cow (WC; ●) and HC fortified milk; α *p* \< 0.05 from baseline for WC fortified milk; β *p* \< 0.05 from baseline for WG fortified milk; \* *p* \< 0.05 from baseline all fortified milks (Sidak corrected post hoc tests).](nutrients-10-01492-g004){#nutrients-10-01492-f004}

![Postprandial subjective digestive symptom and appetite responses. Bloating (**A**), flatulence (**B**), and appetite (**C**). Values represent means ± SEM on a 100 mm scale. Symptom scales were anchored with 0 "no symptom" and 100 "the most severe symptom imaginable". Appetite was anchored with 0 "nothing at all" and 100 "a lot" in response to "How much do you think you can eat?". There was a time × treatment interaction for appetite (*p* \< 0.001). Φ denotes statistical significance *p* \< 0.05 between whole goat (WG; ■) and hydrolysed cow (HC; ○) fortified milks; χ *p* \< 0.05 between whole cow (WC; ●) and HC fortified milks; \* *p* \< 0.05 from baseline for all fortified milks; α *p* \< 0.05 from baseline for WC fortified milk; β *p* \< 0.05 from baseline for WG fortified milk; δ *p* \< 0.05 from baseline for HC fortified milk (Sidak corrected post hoc tests).](nutrients-10-01492-g005){#nutrients-10-01492-f005}

nutrients-10-01492-t001_Table 1

###### 

Nutritional composition per 100 mL prepared fortified milk.

  Nutrient                              Unit            Whole Goat   Whole Cow   Partially Hydrolysed Cow ^†^
  ------------------------------------- --------------- ------------ ----------- ------------------------------
  Energy                                kJ              255          230         360
  Protein                               g               2.2          2.2         2.2
  Fat                                   g               3.1          2.1         3.6
  Total carbohydrates                   g               6.1          7.0         11.0
  Lactose                               g               3.6          3.2         4.4
  Maltodextrin                          g               1.7          2.9         6.6
  Fructose                              g               0.6          0.7         0.0
  Fibre (inulin + oligofructose)        g               0.2          0.3         0.0
  Sodium                                mg              23           19          35
  Vitamins                                                                       
  Total vitamin A (RE)                  mcg             63           63          41
  Vitamin D~3~                          mcg             1.0          1.0         1.0
  Vitamin E (TE)                        mg              1.6          1.6         1.4
  Vitamin C                             mg              9            9           9
  Thiamine                              mcg             62           69          116
  Riboflavin                            mcg             120          137         193
  Niacin                                mg              0.69         0.8         0.6
  Folic acid                            mcg             12           12          21
  Minerals                                                                       
  Calcium                               mg              103          94          122
  Phosphorus                            mg              77           73          68
  Magnesium                             mg              10           6.7         32
  Iron                                  mg              1.0          1.0         1.3
  Zinc                                  mg              0.52         0.50        0.6
  Iodine                                mcg             10           9           14
  Other                                                                          
  Inositol                              mg              7.4          8.3         
  Probiotic cultures                                                             
  *Lactobacillus and Bifidobacterium*   CFU (million)   40           40          40

CFU, colony-forming units; RE, retinol equivalents; TE, tocopherol equivalents. ^†^ Formula was prepared to provide 2.2 g protein per 100 mL; more powder per 100 mL was added than prescribed by the manufacturer to match protein concentration of other formulas. Nutrient values are taken from the product tin as purchased in New Zealand.

nutrients-10-01492-t002_Table 2

###### 

Total amino acid profile per 100 mL prepared fortified milk.

  Amino Acid ^†^   Whole Goat   Whole Cow   Partially Hydrolysed Cow
  ---------------- ------------ ----------- --------------------------
                   mg                       
  Glutamic Acid    470          510         393
  Proline          235          230         120
  Leucine          214          232         249
  Lysine           174          186         196
  Aspartic Acid    161          181         247
  Valine           153          151         126
  Serine           123          111         94.1
  Threonine        115          102         142
  Phenylalanine    109          117         77.8
  lsoleucine       103          123         125
  Tyrosine         77.5         106         60.1
  Alanine          69.6         88.8        110
  Arginine         62.3         79.6        55.8
  Histidine        61.9         66.3        43.4
  Methionine       52.4         63.3        47.9
  Glycine          38.9         45.6        43.2
  Tryptophan       32.1         34.8        47.5
  Cysteine         21.2         20.2        63.7

^†^ Results for aspartic acid and glutamic acid may include contributions of asparagine and glutamine, respectively, converted during hydrolysis.

nutrients-10-01492-t003_Table 3

###### 

Baseline subject characteristics.

  Measure   Unit      Males (*n* = 15)   Females (*n* = 15)           
  --------- --------- ------------------ -------------------- ------- ------------
  Age       years     25.3               2.8                  24.8    2.2
  Weight    kg        74.8               10.1                 58.3    7.7 \*\*\*
  Height    cm        175.0              4.0                  164.0   4.4 \*\*\*
  BMI       kg/m^2^   24.3               2.9                  21.7    2.7 \*
  Glucose   mmol/L    5.4                0.6                  5.0     0.4 \*\*
  Insulin   μU/mL     7.3                0.8                  7.9     0.4
  HOMA-IR             1.8                1.3                  1.7     0.6

^†^ Values presented as means ± SEM from fasting samples collected on all three occasions; ^‡^ Main effects and interactions were analysed by two-factor repeated-measures ANOVA (treatment and sex) with Sidak corrected post hoc tests. There were no differences between group baseline values between treatment days; \* *p* \< 0.05, \*\* *p* \< 0.01, \*\*\* *p* \< 0.001 compared with male subjects.

nutrients-10-01492-t004_Table 4

###### 

Amino acid AUC following whole goat, whole cow, and partially-hydrolysed cow fortified milk.

  Amino Acid ^†^    Whole Goat     Whole Cow      Partially Hydrolysed Cow   *p* Value ^‡^   Post Hoc
  ----------------- -------------- -------------- -------------------------- --------------- --------------------
  Alanine           15392 ± 2104   19273 ± 2486   18960 ± 2475               0.261           
  Lysine            8768 ± 807     7837 ± 852     5903 ± 786                 0.036           \*
  Proline           15374 ± 848    16301 ± 1105   2613 ± 973                 \<0.001         \*\*\*\^\^\^
  Leucine           1771 ± 565     1344 ± 791     −180 ± 547                 0.03            \*\*
  Isoleucine        46 ± 300       558 ± 554      −304 ± 358                 0.219           
  Valine            6138 ± 725     1676 ± 905     −6833 ± 795                \<0.001         \*\*\*\^\^\^\#\#\#
  Tyrosine          489 ± 244      2237 ± 334     −2395 ± 303                \<0.001         \*\*\*\^\^\^\#\#\#
  Methionine        51 ± 115       255 ± 153      −914 ± 126                 \<0.001         \*\*\*\^\^\^
  Phenylalanine     −208 ± 198     −77 ± 189      −2388 ± 226                \<0.001         \*\*\*\^\^\^
  Asparagine        1095 ± 197     1300 ± 207     384 ± 242                  0.003           \*\^
  Citrulline        3204 ± 471     1377 ± 443     2609 ± 582                 0.019           \#\#
  Glutamine         9639 ± 1514    5988 ± 1758    1146 ± 1674                \<0.001         \*\*
  Ornithine         1108 ± 332     791 ± 410      −636 ± 305                 \<0.001         \*\*\*\^
  Histidine         1579 ± 398     1616 ± 453     −1162 ± 322                \<0.001         \*\*\*\^\^\^
  Serine            326 ± 371      −38 ± 435      −1646 ± 385                0.003           \*\*
  Taurine           −3644 ± 2665   −1634 ± 1671   −1025 ± 692                0.566           
  Aspartic Acid     −30 ± 92       −59 ± 106      −172 ± 38                  0.211           
  Glutamic Acid     518 ± 517      652 ± 922      −1347 ± 617                0.027           \*
  Glycine           −2423 ± 731    −2665 ± 666    −3877 ± 732                0.26            
  Hydroxy-proline   −208 ± 53      −330 ± 85      −292 ± 69                  0.359           
  Arginine          1250 ± 725     1167 ± 706     −2431 ± 604                \<0.001         \*\*\^\^
  Threonine         −1108 ± 172    −1299 ± 173    −2160 ± 149                \<0.001         \*\*\*\^\^\^

^†^ Values presented as means ± SEM in μmol·min/mL; ^‡^ Main effects and interactions were analysed by one-factor repeated-measures ANOVA (treatment) with Sidak corrected post hoc tests. \* *p* \< 0.05, \*\* *p* \< 0.01, \*\*\* *p* \< 0.001 between whole goat and partially-hydrolysed cow fortified milk; \^ *p* \< 0.05, \^\^ *p* \< 0.01, \^\^\^ *p* \< 0.001 between whole cow and partially-hydrolysed cow fortified milk; \#\# *p* \< 0.01, \#\#\# *p* \< 0.001 between whole goat and whole cow fortified milk.
